Supernus Pharmaceuticals Inc (SUPN)
Gross Profit Growth
24.74%
Quarterly · Period ending:
SUPN Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported24.74%period ending
Latest reported24.74%period ending
SUPN Quarterly Gross Profit YoY % (38.55% → 24.74%)
Year-over-year change
High-resolution chart · PNG
SUPN gross profit growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Gross Profit Growth |
|---|---|
| 24.7352% | |
| 37.4852% | |
| 27.3563% | |
| 9.5075% | |
| -1.1854% | |
| 5.2821% | |
| 2.3319% | |
| 17.7444% | |
| 31.3937% | |
| -2.2785% | |
| 0.2168% | |
| -11.3524% | |
| -23.4782% | |
| -3.173% | |
| 1.6318% | |
| 16.1805% | |
| 28.6266% | |
| 16.0341% | |
| 13.623% | |
| -2.5182% | |
| -1.7255% | |
| 27.6953% | |
| 29.7831% | |
| 37.4287% | |
| 17.5776% | |
| 11.0454% | |
| -13.7929% | |
| -1.486% | |
| 5.0034% | |
| -6.1514% | |
| 32.5874% | |
| 29.7346% | |
| 33.1911% | |
| 59.5383% | |
| 43.8169% | |
| 42.6455% | |
| 50.9713% | |
| 33.1067% | |
| 47.0184% | |
| 46.9041% | |
| 43.1962% | |
| 54.7803% | |
| 39.77% | |
| -28.9816% | |
| 18.8334% | |
| 208.7807% | |
| 207.7147% | |
| 4,080.3105% | |
| 10,013.3574% | |
| 5,741.4966% | |
| 750.2752% | |
| 1,245.0549% | |
| 204.3956% | |
| -29.3269% | |
| 111.0716% | |
| 727.2727% | |
| -87.8667% | |
| -306.0495% | |
| 38.5501% |